Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Powell, Timothy J ^a   Peng, Yanchun ^a   Berthoud, Tamara K ^b   Blais, Marie Eve ^a   Lillie, Patrick J ^b   Hill, Adrian V S ^b   Rowland Jones, Sarah L ^b   McMichael, Andrew J ^b   Gilbert, Sarah C ^b   Dong, Tao ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; CD57 ANTIGEN; CHEMOKINE RECEPTOR CCR5; EPITOPE; GRANZYME A; GRANZYME B; HLA A ANTIGEN; INFLUENZA VACCINE; PERFORIN; PROTEIN BCL 2; CORE PROTEIN; GRANZYME; HEMAGGLUTININ; HLA A2 ANTIGEN; M1 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; MVA VACCINE; NUCLEOPROTEIN; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIGEN; VIRUS VACCINE;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; ADOLESCENT; ADULT; CLINICAL TRIAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; ORTHOMYXOVIRIDAE; VACCINATION; VIROLOGY;

ORTHOMYXOVIRIDAE;

ADOLESCENT; ADULT; ANTIGENS, CD57; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; GRANZYMES; HEMAGGLUTININS; HLA-A2 ANTIGEN; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE; PERFORIN; RECOMBINANT PROTEINS; VACCINATION; VACCINES, SYNTHETIC; VIRAL CORE PROTEINS; VIRAL MATRIX PROTEINS; VIRAL VACCINES;

EID: 84877038783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062778     Document Type: Article

References (26)

1. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, et al. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-117.
2. Hobson D, Curry RL, Beare AS, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
3. Nicholson KG, Wood JM, Zambon M, (2003) Influenza. Lancet 362: 1733-1745.
4. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370.
5. Lee LY, Ha DL, Simmons C, de Jong MD, Chau NV, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118: 3478-3490.
6. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82: 5161-5166.
7. McMichael AJ, Gotch FM, Noble GR, Beare PA, (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309: 13-17.
8. Plotnicky H, Cyblat-Chanal D, Aubry JP, Derouet F, Klinguer-Hamour C, et al. (2003) The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/K(b) transgenic mice. Virology 309: 320-329.
9. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, et al. (1995) Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 181: 79-91.
10. Cerwenka A, Morgan TM, Dutton RW, (1999) Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol 163: 5535-5543.
11. Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, et al. (2007) Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med 204: 1625-1636.
12. Co MD, Orphin L, Cruz J, Pazoles P, Rothman AL, et al. (2008) Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine 26: 1990-1998.
13. Forrest BD, Pride MW, Dunning AJ, Capeding MR, Chotpitayasunondh T, et al. (2008) Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 15: 1042-1053.
14. Heidema J, Rossen JW, Lukens MV, Ketel MS, Scheltens E, et al. (2008) Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold. J Immunol 181: 5551-5559.
15. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
16. Lillie PJ, Berthoud TK, Powell TJ, Lambe T, Mullarkey C, et al. (2012) A preliminary assessment of the efficacy of a T cell-based influenza vaccine, MVA-NP+M1, in humans. Clin Infect Dis 55: 19-25.
17. Berthoud TK, Hamill M, Lillie PJ, Hwenda L, Collins KA, et al. (2011) Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 52: 1-7.
18. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
19. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, et al. (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8: 379-385.
20. Powell TJ, Fox A, Peng Y, Quynh Mai LT, Lien VT, et al. (2012) Identification of H5N1-Specific T-Cell Responses in a High-risk Cohort in Vietnam Indicates the Existence of Potential Asymptomatic Infections. J Infect Dis 205: 20-27.
21. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, et al. (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280.
22. Makedonas G, Banerjee PP, Pandey R, Hersperger AR, Sanborn KB, et al. (2009) Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity. J Immunol 182: 5560-5569.
23. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, et al. (2008) Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28: 710-722.
24. He XS, Holmes TH, Mahmood K, Kemble GW, Dekker CL, et al. (2008) Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines. J Infect Dis 197: 803-811.
25. Terajima M, Cruz J, Leporati AM, Orphin L, Babon JA, et al. (2008) Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients. J Virol 82: 9283-9287.
26. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, et al. (2010) Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 84: 6527-6535.